rs57761448

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_020964.3(EPG5):​c.7558-11G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.105 in 1,610,974 control chromosomes in the GnomAD database, including 9,480 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.10 ( 884 hom., cov: 33)
Exomes 𝑓: 0.11 ( 8596 hom. )

Consequence

EPG5
NM_020964.3 intron

Scores

2
Splicing: ADA: 0.00005633
2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: -3.42

Publications

5 publications found
Variant links:
Genes affected
EPG5 (HGNC:29331): (ectopic P-granules 5 autophagy tethering factor) This gene encodes a large coiled coil domain-containing protein that functions in autophagy during starvation conditions. Mutations in this gene cause Vici syndrome. [provided by RefSeq, Aug 2015]
EPG5 Gene-Disease associations (from GenCC):
  • Vici syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, Orphanet, G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.83).
BP6
Variant 18-45852660-C-T is Benign according to our data. Variant chr18-45852660-C-T is described in ClinVar as Benign. ClinVar VariationId is 402831.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.16 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
EPG5NM_020964.3 linkc.7558-11G>A intron_variant Intron 43 of 43 ENST00000282041.11 NP_066015.2 Q9HCE0-1Q9BTI0

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
EPG5ENST00000282041.11 linkc.7558-11G>A intron_variant Intron 43 of 43 1 NM_020964.3 ENSP00000282041.4 Q9HCE0-1

Frequencies

GnomAD3 genomes
AF:
0.104
AC:
15886
AN:
152058
Hom.:
886
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0906
Gnomad AMI
AF:
0.115
Gnomad AMR
AF:
0.113
Gnomad ASJ
AF:
0.141
Gnomad EAS
AF:
0.169
Gnomad SAS
AF:
0.0462
Gnomad FIN
AF:
0.102
Gnomad MID
AF:
0.0823
Gnomad NFE
AF:
0.109
Gnomad OTH
AF:
0.103
GnomAD2 exomes
AF:
0.105
AC:
26107
AN:
247652
AF XY:
0.101
show subpopulations
Gnomad AFR exome
AF:
0.0888
Gnomad AMR exome
AF:
0.110
Gnomad ASJ exome
AF:
0.134
Gnomad EAS exome
AF:
0.186
Gnomad FIN exome
AF:
0.0989
Gnomad NFE exome
AF:
0.109
Gnomad OTH exome
AF:
0.103
GnomAD4 exome
AF:
0.105
AC:
153363
AN:
1458798
Hom.:
8596
Cov.:
31
AF XY:
0.104
AC XY:
75148
AN XY:
725762
show subpopulations
African (AFR)
AF:
0.0883
AC:
2947
AN:
33382
American (AMR)
AF:
0.109
AC:
4850
AN:
44530
Ashkenazi Jewish (ASJ)
AF:
0.139
AC:
3607
AN:
25974
East Asian (EAS)
AF:
0.147
AC:
5816
AN:
39676
South Asian (SAS)
AF:
0.0452
AC:
3892
AN:
86048
European-Finnish (FIN)
AF:
0.103
AC:
5467
AN:
53254
Middle Eastern (MID)
AF:
0.0627
AC:
361
AN:
5756
European-Non Finnish (NFE)
AF:
0.108
AC:
120142
AN:
1109908
Other (OTH)
AF:
0.104
AC:
6281
AN:
60270
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.468
Heterozygous variant carriers
0
5958
11916
17874
23832
29790
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
4392
8784
13176
17568
21960
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.104
AC:
15899
AN:
152176
Hom.:
884
Cov.:
33
AF XY:
0.103
AC XY:
7656
AN XY:
74396
show subpopulations
African (AFR)
AF:
0.0904
AC:
3752
AN:
41518
American (AMR)
AF:
0.114
AC:
1741
AN:
15280
Ashkenazi Jewish (ASJ)
AF:
0.141
AC:
490
AN:
3472
East Asian (EAS)
AF:
0.169
AC:
873
AN:
5168
South Asian (SAS)
AF:
0.0458
AC:
221
AN:
4822
European-Finnish (FIN)
AF:
0.102
AC:
1082
AN:
10598
Middle Eastern (MID)
AF:
0.0884
AC:
26
AN:
294
European-Non Finnish (NFE)
AF:
0.109
AC:
7391
AN:
68000
Other (OTH)
AF:
0.103
AC:
218
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
717
1433
2150
2866
3583
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
180
360
540
720
900
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.108
Hom.:
1553
Bravo
AF:
0.106
Asia WGS
AF:
0.0850
AC:
298
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
Mar 29, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency -

Jan 24, 2024
Unidad de Genómica Garrahan, Hospital de Pediatría Garrahan
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is classified as Benign based on local population frequency. This variant was detected in 25% of patients studied by a panel of primary immunodeficiencies. Number of patients: 24. Only high quality variants are reported. -

not provided Benign:2
Apr 02, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Vici syndrome Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.83
CADD
Benign
0.026
DANN
Benign
0.40
PhyloP100
-3.4
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.000056
dbscSNV1_RF
Benign
0.0040
SpliceAI score (max)
0.030
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs57761448; hg19: chr18-43432625; COSMIC: COSV56344727; COSMIC: COSV56344727; API